Market Overview

Social Media Outlook for Thursday 17 (PCYC, DRI, MLM, SPLS)

Related PCYC
Pharmacyclics Reports IMRUVICA Data Shows Safety, Durability of Response at Two-Year Follow-Up in Mantle Cell Lymphoma
AstraZeneca And Pharmacyclics Enter Clinical Trial Collaboration To Evaluate Imbruvica In Hematologic Cancers

In recent years, traders and investors have increasingly turned to social media to discuss their investments. Now, interested parties can get a scientific look at what is being discussed on a weekly, monthly, and even hourly basis.

Provided by Social Market Analytics, here is the social media outlook for Thursday, May 17.

Most Bullish

Pharmacyclics (NASDAQ: PCYC) is trading up over 3%. Rodman & Renshaw boosted the company's price target.

Darden Restaurants (NYSE: DRI)

Most Bearish

Martin Marietta (NYSE: MLM) is trading down about 1.25%. Yesterday, shares plunged when hedge fund manager David Einhorn mentioned the company as a possible short target.

Staples (NASDAQ: SPLS) is trading down over 2%.

Most Discussed

Apple (NASDAQ: AAPL) frequently sits atop this list. Shares are currently trading near $538.

JPMorgan (NYSE: JPM) continues to be discussed in the wake of the company's announcement that it had lost roughly $2 billion trading last week.

Google (NASDAQ: GOOG), like Apple, is also frequently discussed. Shares are currently trading near $632.

Herbalife (NYSE: HLF) is currently trading down over 5%. Shares spiked up higher yesterday after hedge fund manager David Einhorn failed to mention them in his presentation as expected.

Interested in getting more information about stock trends on social media? Signup for the Social Market Analytics newsletter on their website.

Latest Ratings for PCYC

DateFirmActionFromTo
Nov 2014Morgan StanleyMaintainsEqual-weight
Nov 2014JMP SecuritiesMaintainsMarket Outperform
Nov 2014NomuraMaintainsBuy

View More Analyst Ratings for PCYC
View the Latest Analyst Ratings

Posted-In: Earnings News Hedge Funds Price Target Analyst Ratings Movers Tech Trading Ideas Best of Benzinga

 

Related Articles (AAPL + DRI)

Around the Web, We're Loving...

Get Benzinga's Newsletters